Histone H1–DNA nucleosomal complex

The Histone H1–DNA nucleosomal complex is a fundamental structural component of eukaryotic chromatin, consisting of the linker histone H1 associated with the nucleosome core particle and linker DNA. Under physiological conditions, these complexes are sequestered within the nucleus of healthy cells and are inaccessible to the immune system or therapeutic antibodies due to the integrity of the nuclear and plasma membranes. In the context of oncology, however, the rapid and disorganized growth of solid tumors often results in a necrotic core where cell membranes become permeable or disintegrate, thereby exposing these normally hidden intracellular antigens to the extracellular environment. This exposure provides a unique, universal, and stable target for a class of therapies known as Tumor Necrosis Therapy (TNT). Monoclonal antibodies designed to recognize the Histone H1–DNA complex can deliver potent therapeutic payloads—including radioactive isotopes like Iodine-131 or proinflammatory cytokines like Interleukin-12—directly into the necrotic regions of a tumor. This targeted approach allows for the accumulation of high concentrations of the therapeutic agent within the tumor mass, leading to the destruction of adjacent viable cancer cells through a bystander effect while minimizing systemic toxicity and damage to healthy, intact tissues.

Other names

DNA-histone H1 complexNecrotic DNA-histone complexInsoluble intracellular antigensTumor Necrosis Therapy targetTNT targetNecrotic core antigen

Targeted delivery of radionuclides or cytokines to necrotic tumor regions to induce bystander cell death and immune activation.